These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 22061638)

  • 1. Efficient synthesis of a novel m-phenylene derivative as a selective EP4 agonist inducing follicular growth and maturation in the ovary.
    Hayashi R; Hosono Y; Nakatsuji K; Tanaka Y; Mori T; Kanno T; Makita K; Moriwaki M; Ohyama T; Ochi Y; Inada C; Isogaya M
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7505-8. PubMed ID: 22061638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of novel modified γ-lactam prostanoids as EP4 subtype-selective agonists.
    Kambe T; Maruyama T; Nagase T; Ogawa S; Minamoto C; Sakata K; Maruyama T; Nakai H; Toda M
    Bioorg Med Chem; 2012 Jan; 20(2):702-13. PubMed ID: 22204740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment.
    Jiang GL; Im WB; Donde Y; Wheeler LA
    J Pharmacol Exp Ther; 2010 Dec; 335(3):546-52. PubMed ID: 20833794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
    Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
    Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on improvement of blood flow in the chronically compressed cauda equina: comparison between a selective prostaglandin E receptor (EP4) agonist and a prostaglandin E1 derivate.
    Sekiguchi M; Konno S; Kikuchi S
    Spine (Phila Pa 1976); 2006 Apr; 31(8):869-72. PubMed ID: 16622373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
    Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
    Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central PGE2 exhibits anxiolytic-like activity via EP1 and EP4 receptors in a manner dependent on serotonin 5-HT1A, dopamine D1 and GABAA receptors.
    Suzuki C; Miyamoto C; Furuyashiki T; Narumiya S; Ohinata K
    FEBS Lett; 2011 Jul; 585(14):2357-62. PubMed ID: 21693121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-prostanoid (EP)2/EP4 receptor-dependent maturation of human monocyte-derived dendritic cells and induction of helper T2 polarization.
    Kubo S; Takahashi HK; Takei M; Iwagaki H; Yoshino T; Tanaka N; Mori S; Nishibori M
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1213-20. PubMed ID: 14872092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the nature of the follicle-stimulating signal delivered to the ovary during exogenously controlled follicular maturation. A search into the immunological and biological attributes and the molecular composition of two preparations of urofollitropin.
    Ulloa-Aguirre A; Zambrano E; Timossi C; Olivares A; Quintanar A; Aguinaga M; Díaz-Cueto L; Méndez JP
    Arch Med Res; 1995; 26 Spec No():S219-30. PubMed ID: 8845653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of calcitonin expression in the chicken ovary: influence of follicular maturation and ovarian steroids.
    Krzysik-Walker SM; Ocón-Grove OM; Maddineni SB; Hendricks GL; Ramachandran R
    Biol Reprod; 2007 Oct; 77(4):626-35. PubMed ID: 17582014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulatory system and physiological significance of local factors in the ovary during follicular development and maturation].
    Yoshimura Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Aug; 47(8):763-74. PubMed ID: 7594885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, pharmacophore modeling and in vitro activity of 10,11-dihydrodibenzo[b,f]oxepine-4-carboxamide derivatives as novel and potent antagonists of the prostaglandin EP4 receptor.
    Stasi LP; Bhimani K; Borriello M; Canciani L; Caselli G; Colace F; Ferioli C; Kaswala M; Mennuni L; Piepoli T; Pucci S; Salvi M; Shirsath V; Zanelli T; Zerbi S
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6336-40. PubMed ID: 21930381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of the putative structure of eupomatilone-6.
    Gurjar MK; Cherian J; Ramana CV
    Org Lett; 2004 Feb; 6(3):317-9. PubMed ID: 14748582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration, in female guinea pigs, of the inhibitory action exerted at the begining of the estrous cycle by progesterone, on growth of ovarian follicles].
    Jesel L
    C R Seances Soc Biol Fil; 1971; 165(3):693-5. PubMed ID: 4258266
    [No Abstract]   [Full Text] [Related]  

  • 15. Bladder outlet obstruction induced expression of prostaglandin E2 receptor subtype EP4 in the rat bladder: a possible counteractive mechanism against detrusor overactivity.
    Beppu M; Araki I; Yoshiyama M; Du S; Kobayashi H; Zakoji H; Takeda M
    J Urol; 2011 Dec; 186(6):2463-9. PubMed ID: 22019172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma.
    Hori R; Nakagawa T; Sugimoto Y; Sakamoto T; Yamamoto N; Hamaguchi K; Ito J
    Neuroscience; 2009 Jun; 160(4):813-9. PubMed ID: 19303430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist.
    Toyoda H; Terai H; Sasaoka R; Oda K; Takaoka K
    Bone; 2005 Oct; 37(4):555-62. PubMed ID: 16027058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-inflammatory mechanism of prostaglandin e2 receptor 4 activation in rat experimental autoimmune myocarditis.
    Ngoc PB; Suzuki J; Ogawa M; Hishikari K; Takayama K; Hirata Y; Nagai R; Isobe M
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):365-72. PubMed ID: 21383594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanogel-based scaffold delivery of prostaglandin E(2) receptor-specific agonist in combination with a low dose of growth factor heals critical-size bone defects in mice.
    Kamolratanakul P; Hayata T; Ezura Y; Kawamata A; Hayashi C; Yamamoto Y; Hemmi H; Nagao M; Hanyu R; Notomi T; Nakamoto T; Amagasa T; Akiyoshi K; Noda M
    Arthritis Rheum; 2011 Apr; 63(4):1021-33. PubMed ID: 21190246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells.
    Friis UG; Stubbe J; Uhrenholt TR; Svenningsen P; Nüsing RM; Skøtt O; Jensen BL
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F989-97. PubMed ID: 15985651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.